UBS analyst Joshua Spector lowered the firm’s price target on Albemarle to $130 from $140 and keeps a Neutral rating on the shares. The price target decrease reflects a lower price level in 2024 and longer-term, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALB:
